Work

Serial circulating tumor DNA (ctDNA) measurement to predict progression in patients (pts) with advanced urothelial carcinoma (aUC).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.6_suppl.558

Authors: Dario Martin Villamar, Kyrillus Shohdy, Yen Thi Kim Hong Cao, Janson Trieu, Kristin Sedgwick Price, Rebecca Nagy, Ana M. Molina, Scott T. Tagawa, David M. Nanus, Cora N. Sternberg, Guru Sonpavde, Petros Grivas, Nicholas J. Vogelzang, Bishoy Morris Faltas

Institutions: NewYork–Presbyterian Hospital, Weill Cornell Medicine, University of Nevada, Las Vegas, Guardant (United States), Dana-Farber Cancer Institute, University of Washington, Comprehensive Cancer Centers of Nevada

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3008549122

Cites:

Cited by:

Related to: 10